Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 64 results for "leerink swann llc"

Navigant Adds Leerink's Life Sciences Practice
Mergers & Acquisitions

Leerink Swann Consulting Joins Navigant

By a News Reporter-Staff News Editor at Biotech Week -- Navigant (NYSE: NCI) announced that it has acquired substantially all of the Life Sciences practice of Leerink Swann Consulting, LLC , the consulting arm of Leerink Holdings, LLC , a leading ... 4 Traders, 1 week ago
Navigant Adds Leerink's Life Sciences Practice Mergers & Acquisitions, 2 weeks ago

1 images for "leerink swann llc"

American Banking News, 4 months ago

Mylan Price Target Cut to $58.00 by Analysts at Leerink Swann (MYL)

Tweet [embedded content] Research analysts at Leerink Swann reduced their target price on shares of Mylan (NYSE:MYL) to $58.00 in a report released on Friday, AnalystRatings.Net reports. The firm currently has an outperform rating on the ...
 Zolmax News1 week ago Mylan Given New $58.00 Price Target at Leerink Swann (MYL)  American Banking News2 weeks ago Leerink Swann Lowers Mylan Price Target to $58.00 (MYL)  Mideast Time2 weeks ago Investment Analysts Price Target Changes for March, 28th (ACN, AGEND, AGIO, AOI, ARUN, ASPX, AVGO, AVH, BAX, BGC)  Mideast Time3 weeks ago

Mylan Rating Increased to Buy at Citic Securities Co., Ltd (MYL)

MYL has been the subject of a number of other recent research reports. Analysts at Leerink Swann cut their price target on shares of Mylan to $58.00 in a research note on Friday. They now have an outperform rating on the stock. Separately, analysts ...
 American Banking News1 week ago Citigroup Inc. Upgrades Mylan to Buy (MYL)  American Banking News2 weeks ago

Mylan Given Consensus Rating of Buy by Brokerages (NASDAQ:MYL)

Mylan (NASDAQ:MYL) has been given an average rating of Buy by the fifteen brokerages that are covering the stock, . One analyst has rated the stock with a sell recommendation, four have given a hold recommendation and nine have given a buy ...
 American Banking News1 day ago Mylan Upgraded by Citigroup Inc. to Buy (MYL)  Mideast Time2 weeks ago
Mideast Time

Research Analysts New Coverage for April, 14th (ACRX, AGII, AI, AKBA, AO, APAM, AUDC, BCRX, BLDP, CPRX)

Tweet [embedded content] Research Analysts new coverage for Monday, April 14th: Roth Capital started coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX) . The firm issued a buy rating and a $22.00 target price on the stock. ...
 Mideast Time5 days ago

PlacementTracker Publishes First Quarter 2014 PIPE Market League Tables

(GLOBE NEWSWIRE) -- PlacementTracker, the leading source for data and analysis on the PIPE market, today announced the most active investment banks, institutional investors, issuer counsels, investor counsels, and placement agent counsels in the ...
 Yahoo! Finance1 week ago

KaloBios Pharmaceuticals Sets New 1-Year Low at $2.56 (KBIO)

KaloBios Pharmaceuticals (NASDAQ:KBIO) shares hit a new 52-week low during trading on Thursday , reports. The company traded as low as $2.56 and last traded at $2.58, with a volume of 315,785 shares changing hands. The stock had previously closed at ...
 American Banking News2 weeks ago TRANSCEPT PHARMACEUTICALS INC - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations  TMC Net1 month ago Transcept Pharmaceuticals Reports Fourth Quarter And Full Year 2013 Financial Results  BusinessWeek1 month ago

Endo Deal Provides Tax Edge

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers, click the "Reprints" link at the top of any article. Its acquisition of Paladin will allow Endo ...
 Treasury & Risk Management3 weeks ago

Oracle Partners Announces Its Proxy Contest Against Biolase, Inc.

/PRNewswire/ -- Oracle Partners, L.P. ("Oracle"), Biolase, Inc.'s ("Biolase" or the "Company") (Nasdaq: BIOL) largest shareholder, announces its nomination of four independent directors for election to the Biolase Board, citing management and Board ...
 4 Traders1 month ago

Inogen raises $70.57 million in initial public offering (IPO)

Deal In Brief Feb 21, 2014 (MarketLine Financial Deals Tracker via COMTEX News Network) -- Inogen, Inc., a US-based developer, manufacturer and marketer of oxygen concentrators, has raised $70.57 million in an initial public offering (IPO) of ...
 PredictWallStreet1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - leerink swann llc
Get updated on latest news & your favorite topics right in your inbox!
More     Less